ASXC Asensus Surgical Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: ASXC

Price (delayed)

$0.2525

Market cap

$68.68M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.31

Enterprise value

$55.62M

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the Clinical Intelligence to enable consistently superior outcomes ...

Highlights
The revenue has soared by 53% from the previous quarter and by 21% YoY
The gross margin is up by 46% since the previous quarter
Asensus Surgical's gross profit has decreased by 21% YoY but it has increased by 18% from the previous quarter
The quick ratio has dropped by 71% year-on-year and by 29% since the previous quarter
ASXC's equity has dropped by 66% year-on-year and by 29% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://asensus.com
Peers: OFIX NVRO NURO

Key stats

What are the main financial stats of ASXC
Market
Shares outstanding
271.99M
Market cap
$68.68M
Enterprise value
$55.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2
Price to sales (P/S)
7.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.48
Earnings
Revenue
$8.58M
EBIT
-$78.12M
EBITDA
-$74.39M
Free cash flow
-$64.19M
Per share
EPS
-$0.31
Free cash flow per share
-$0.26
Book value per share
$0.13
Revenue per share
$0.03
TBVPS
$0.23
Balance sheet
Total assets
$59.09M
Total liabilities
$25.67M
Debt
$5.68M
Equity
$33.41M
Working capital
$23.76M
Liquidity
Debt to equity
0.17
Current ratio
2.88
Quick ratio
2.08
Net debt/EBITDA
0.18
Margins
EBITDA margin
-867.3%
Gross margin
-53.4%
Net margin
-914.5%
Operating margin
-915.3%
Efficiency
Return on assets
-103%
Return on equity
-141.4%
Return on invested capital
-153.1%
Return on capital employed
-168.1%
Return on sales
-910.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASXC stock price

How has the Asensus Surgical stock price performed over time
Intraday
-2.88%
1 week
-9.21%
1 month
-11.4%
1 year
-68.83%
YTD
-20.82%
QTD
9.78%

Financial performance

How have Asensus Surgical's revenue and profit performed over time
Revenue
$8.58M
Gross profit
-$4.58M
Operating income
-$78.5M
Net income
-$78.43M
Gross margin
-53.4%
Net margin
-914.5%
The revenue has soared by 53% from the previous quarter and by 21% YoY
The gross margin is up by 46% since the previous quarter
The operating margin has increased by 37% since the previous quarter and by 16% year-on-year
Asensus Surgical's net margin has increased by 35% QoQ and by 14% YoY

Growth

What is Asensus Surgical's growth rate over time

Valuation

What is Asensus Surgical stock price valuation
P/E
N/A
P/B
2
P/S
7.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.48
ASXC's EPS is up by 6% since the previous quarter and by 3.1% year-on-year
ASXC's equity has dropped by 66% year-on-year and by 29% since the previous quarter
The price to book (P/B) is 29% higher than the 5-year quarterly average of 1.6 and 3% higher than the last 4 quarters average of 2.0
The price to sales (P/S) is 75% lower than the 5-year quarterly average of 29.8 and 51% lower than the last 4 quarters average of 15.3
The revenue has soared by 53% from the previous quarter and by 21% YoY

Efficiency

How efficient is Asensus Surgical business performance
Asensus Surgical's return on invested capital has shrunk by 139% YoY and by 33% QoQ
Asensus Surgical's return on equity has shrunk by 131% YoY and by 29% QoQ
The company's return on assets has shrunk by 90% YoY and by 18% QoQ
ASXC's ROS is up by 35% since the previous quarter and by 14% year-on-year

Dividends

What is ASXC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASXC.

Financial health

How did Asensus Surgical financials performed over time
The total assets is 130% more than the total liabilities
The quick ratio has dropped by 71% year-on-year and by 29% since the previous quarter
The current ratio has dropped by 65% year-on-year and by 24% since the previous quarter
Asensus Surgical's debt is 83% lower than its equity
The company's debt to equity has surged by 183% YoY and by 42% QoQ
ASXC's equity has dropped by 66% year-on-year and by 29% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.